Human African trypanosomiasis (Q56135184)

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Sleeping sickness in Uganda: a thin line between two fatal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Molecular analysis of archived blood slides reveals an atypical human Trypanosoma infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Trypanosoma brucei ssp. and T congolense: mixed human infection in Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Human trypanosomiasis caused by Trypanosoma evansi in India: the first case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

The history of African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

The fall and rise of sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Re-emergence of epidemic sleeping sickness in southern Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

The situation of sleeping sickness in Angola: a calamity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

In the heart of darkness: sleeping sickness in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Sleeping sickness resurgence in the DRC: the past decade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

The rise and fall of sleeping sickness.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Retaking sleeping sickness control in Angola

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Trypanosomiasis control, Democratic Republic of Congo, 1993-2003

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Eliminating human African trypanosomiasis: where do we stand and what comes next?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Quantifying the level of under-detection of Trypanosoma brucei rhodesiense sleeping sickness cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

The burden of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

African trypanosomiasis gambiense, Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

A traveler returning from Central Africa with fever and a skin lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Skin features accompanying imported human African trypanosomiasis: hemolymphatic Trypanosoma gambiense infection among two French expatriates with dermatologic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Cluster of African trypanosomiasis in travelers to Tanzanian national parks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-2002. A 37-year-old man with fever, hepatosplenomegaly, and a cutaneous foot lesion after a trip to Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

African trypanosomiasis in travelers returning to the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Imported African Trypanosomiasis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Factors affecting trypanosome maturation in tsetse flies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

The trypanosome lytic factor of human serum and the molecular basis of sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

African trypanosomes: intracellular trafficking of host defense molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Switching trypanosome coats: what's in the wardrobe?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Analysis of the VSG gene silent archive in Trypanosoma brucei reveals that mosaic gene expression is prominent in antigenic variation and is favored by archive substructure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

From silent genes to noisy populations-dialogue between the genotype and phenotypes of antigenic variation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Kinetoplastids: related protozoan pathogens, different diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Wild fauna as a probable animal reservoir for Trypanosoma brucei gambiense in Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

New developments in human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Detection of T.b. rhodesiense trypanosomes in humans and domestic animals in south east Uganda by amplification of serum resistance-associated gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

High prevalence of Trypanosoma brucei gambiense group 1 in pigs from the Fontem sleeping sickness focus in Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Migration of African trypanosomes across the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Estimates of the duration of the early and late stage of gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Clinical aspects of 2541 patients with second stage human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

African trypanosomosis: from immune escape and immunopathology to immune intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Why trypanosomes cause sleeping sickness.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Human African trypanosomiasis-neurological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Myocarditis in Trypanosoma rhodesiense infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Cardiac involvement in African and American trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Sleeping glands? - The role of endocrine disorders in sleeping sickness (T.b. gambiense Human African Trypanosomiasis).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Neuroendocrine dysfunction in African trypanosomiasis. The role of cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

East African trypanosomiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

African sleeping sickness in tourists returning from Tanzania: the first 2 Italian cases from a small outbreak among European travelers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Genetic characterization of Trypanosoma brucei gambiense and clinical evolution of human African trypanosomiasis in Cote d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Clinical and biological evolution of human trypanosomiasis in C te d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Characterization of Trypanosoma brucei s.l. infecting asymptomatic sleeping-sickness patients in Côte d'Ivoire: a new genetic group?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Clinical and serologic responses to human 'apathogenic' trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Severity of human african trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Options for field diagnosis of human african trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Review Article: cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Field evaluation of the CATT/Trypanosoma brucei gambiense on blood-impregnated filter papers for diagnosis of human African trypanosomiasis in southern Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Evaluation of LATEX/T.b.gambiense for mass screening of Trypanosoma brucei gambiense sleeping sickness in Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Serodiagnosis of sleeping sickness in the Republic of the Congo: comparison of indirect immunofluorescent antibody test and card agglutination test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Absence of the LiTat 1.3 (CATT antigen) gene in Trypanosoma brucei gambiense stocks from Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

A semi-quantitative ELISA for detection of Trypanosoma brucei gambiense specific antibodies in serum and cerebrospinal fluid of sleeping sickness patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Parasitological diagnosis of human African trypanosomiasis: a comparison of the QBC® and miniature anion-exchange centrifugation techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Trypanosoma brucei: Miniature anion-exchange centrifugation technique for detection of low parasitaemias: Adaptation for field use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Cost-effectiveness of algorithms for confirmation test of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

[Validity, cost and feasibility of the mAECT and CTC confirmation tests after diagnosis of African of sleeping sickness]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African Trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in southern Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Attitude towards CATT-positive individuals without parasitological confirmation in the African Trypanosomiasis (T.b. gambiense) focus of Quiçama (Angola)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Diagnosing human African trypanosomiasis in Angola using a card agglutination test: observational study of active and passive case finding strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Diagnosing central nervous system trypanosomiasis: two stage or not to stage?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Stage determination and therapeutic decision in human African trypanosomiasis: value of polymerase chain reaction and immunoglobulin M quantification on the cerebrospinal fluid of sleeping sickness patients in Côte d'Ivoire.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Blood–cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Cerebrospinal-fluid IgM in patients with sleeping-sickness.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Human African trypanosomiasis: quantitative and qualitative assessment of intrathecal immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Dot enzyme-linked immunosorbent assay for more reliable staging of patients with Human African trypanosomiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

A new initiative for the development of new diagnostic tests for human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Molecular dipstick test for diagnosis of sleeping sickness.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Candidate protein selection for diagnostic markers of African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

African trypanosomiasis: sensitive and rapid detection of the sub-genus Trypanozoon by loop-mediated isothermal amplification (LAMP) of parasite DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Proteomic fingerprinting for the diagnosis of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

A novel and accurate diagnostic test for human African trypanosomiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Pentamidine dosage: a base/salt confusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

The pharmacokinetics of eflornithine (alpha-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Enantioselective and nonlinear intestinal absorption of eflornithine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Eflornithine for the treatment of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Public-private partnership works to stamp out sleeping sickness in Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Crisis, what crisis? Control of Rhodesian sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Glossina austeni (Diptera: Glossinidae) eradicated on the island of Unguja, Zanzibar, using the sterile insect technique

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Less is more: restricted application of insecticide to cattle to improve the cost and efficacy of tsetse control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960829-1

7 January 2021